Healthcare Today Michigan
SEE OTHER BRANDS

The best health and wellness news from Michigan

Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

Press releases published on July 7, 2025

CORRECTING AND REPLACING – Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets
Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
CORRECTION – Dr. Anosh Ahmed Supports Trump’s Statement on Chicago, Citing Ongoing Public Safety and Policy Challenges
The National Lung Health Alliance Warns that Politicizing Immunization Risks Lives – Especially for Canadians with Lung Conditions
Lifestyle Expert Meaghan Murphy Shares Her Favorite Wellness Tech for Summer Recovery with YourUpdateTV
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option
The American Society of Pain and Neuroscience (ASPN) Publishes Consensus Guidelines for the Use of 60-Day Peripheral Nerve Stimulation (PNS) Therapy, Highlighting Strong Clinical Applications for SPR® SPRINT® PNS
Joybird’s Treehouse to Host Free Webinar on Academic Success for Underserved Students
Corza Medical Announces the Launch of the Expanded Onatec Ophthalmic Suture Portfolio
Skin Care and Laser Physicians of Beverly Hills Welcomes Double Board-Certified Dermatologist
Immix Biopharma Announces Accelerated NEXICART-2 Clinical Trial Progress in relapsed/refractory AL Amyloidosis
Nudj Health Appoints Dr. Padmaja Patel as Chief Medical Officer to Advance Lifestyle Medicine Services
Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Development 
SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
Ophthalmology Drugs Market to Reach $26.28 Billion by 2030—Vision Care Becomes a Strategic Growth Pillar | MarketsandMarkets™.
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions